bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.10.28.762498

Yeast surface display reveals structure-dependent β-glucan association with the plant immune receptor AtIGP1

Menn, B.·Molina, A.·Jorda, L.·Pauly, M.·Ramirez, V.
View original source ↗Export metadata ↓

Abstract

Cell wall-derived oligosaccharides can function as immune-active signals in plants and trigger pattern-triggered immunity (PTI) through pattern recognition receptors (PRRs). In Arabidopsis thaliana, the leucine-rich repeat malectin (LRR-MAL) receptor kinase IGP1 (impaired in glycan perception 1) contributes to immune responses induced by cellulose- and mixed-linkage {beta}-1,3/1,4-glucan (MLG)-derived oligosaccharides, although whether MLG-derived oligosaccharides are directly recognized by AtIGP1 needs further clarification. We established a Saccharomyces cerevisiae surface-display system in which the AtIGP1 extracellular domain (ECD) is presented at the yeast cell surface, allowing oligosaccharide recognition to be examined separately from downstream plant signaling and without receptor purification. Previously, cellulose-derived oligosaccharides have been shown to elicit plant defense responses via AtIGP1. Here, surface-displayed AtIGP1 retained the ability to recognize fluorescently labeled cellotriose (CEL3) and cellopentaose (CEL5) ligands, supporting functional presentation of the receptor for investigating glycan recognition in a heterologous context. Using this platform, we investigated the association of AtIGP1 with fluorescently labeled MLG-derived oligosaccharides differing in degree of polymerization (DP) and glycosidic linkage arrangement. This analysis revealed a specific, competitively displaceable association with MLG DP2 (G3G; laminaribiose), whereas the DP3 (G4G3G) and DP4 (G4G4G3G) structures tested showed no detectable association. To test whether this association is relevant in planta, we treated A. thaliana seedlings with unlabeled MLG DP2, which induced a cytosolic Ca2+ response, an early readout of immune activation. This response was markedly reduced in the igp1-3 mutant. Together, these results identify laminaribiose as an additional candidate ligand of AtIGP1. The established yeast surface-display platform thus provides an approach for testing candidate oligosaccharides for association with the extracellular domains of plant PRRs.

Explore related subjects

synthetic biologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Menn, B., Molina, A., Jorda, L., Pauly, M., Ramirez, V.. 2026-10-29. Yeast surface display reveals structure-dependent β-glucan association with the plant immune receptor AtIGP1. https://doi.org/10.64898/2026.10.28.762498

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

E. coli-produced nanobody fusions as a pan-serotype platform for AAV purification, quantification, and detection

Research, production and application of the recombinant adeno-associated virus (rAAV) require versatile tools for rapid and cost-effective advances. We developed fusion constructs with the pan-serotype, AAV-binding VHH-antibody-fragment named nanobody AAVX and devised procedures for AAV purification, quantification, and detection. Starting from an amino acid sequence, we cytosolically expressed in E. coli nanobody AAVX carrying various tags and fusion partners. Very efficient soluble production followed by a one-step immobilized metal-ion affinity chromatography (IMAC) yielded mostly >90% pure protein. Crosslinking AAVX with an agarose matrix enabled efficient purification of intact AAV2 and AAV5 capsids from cell lysates, as assessed by qPCR and ELISA. AAVX also supported effective AAV quantification by ELISA, as capture reagent and, when fused to luciferase, as detection reagent. Using tagged AAVX and streptavidin biosensors, we developed a rapid and label-free quantification assay of AAV capsids by biolayer interferometry (BLI). Finally, immunostaining with an AAVX-eGFP fusion visualized AAV capsids in fixed HEK-293 cells by fluorescence microscopy. Collectively, these results establish nanobody AAVX fusion proteins as versatile and readily customizable tools for AAV research and bioprocessing.

synthetic biology↗
bioRxiv2026

Duality Vaccination through Nanodesign of Click-Ligated B-Cell Inhibitory Receptor Bridging

Synthesis of precise and robust molecular architectures is critical to harness the power of the immune system. The dimensions, rigidity and multivalency of nanoparticles contribute to eliciting high levels of antibodies from vaccination. However, antibodies vary hugely in quality: some antibodies are highly effective at neutralizing pathogens, while others provide little or no benefit. Here we establish switchable and modular platforms for protein and nanoparticle assembly that program the target of antibody responses. We introduce Duality vaccination: the simultaneous delivery of activating and inhibitory stimuli for focusing immune responses. To construct activatory immunogens, we employ click biology with spontaneous amidation to functionalize plug-and-display self-assembling porous dodecahedral nanocages. We construct inhibitory immunogens using SpyMask protease-gated bispecific assembly, ligating the antigen to binders that bridge the B cell receptor to immune checkpoint receptors. This dual immunogen architecture tailors the elicited antibodies to down-modulate undesired B cell responses. We establish the effect of temporal and spatial separation of activatory and inhibitory immunogen delivery. We further explore sensitivity to valency, linker flexibility and adjuvant delivery, employing model targets and coronavirus antigens. Dual programmable functionalization identifies key nanodesign features to control in vivo outputs, providing logic-gating towards urgent challenges in the creation of protective vaccines.

synthetic biology↗
bioRxiv2026

A Synthetic Virology Platform for Rapid Prototyping of Influenza A Virus mutants

Influenza A virus (IAV) remains a significant public health threat, with the need for effective vaccines and antiviral therapies remaining a high priority. In vitro testing is paramount in studying novel IAV viruses and their immunogenicity. To address this need, we developed a synthetic virology approach to rapidly prototype and test IAV mutants with altered antigenic sites. By strategically inserting restriction sites within an ambisense plasmid, we generated a tool where we can seamlessly replace either 1) the full hemagglutinin (HA), 2) the HA globular head domain to generate head/stalk chimeras or 3) the five canonical antigenic sites. The cloning inserts can be computationally designed and artificially synthesized, enabling rescue of synthetic Influenza A viruses. Using this platform we rescued IAV H1N1, H3N2 & H5N1, and went on to prototype their respective antigenic site mutants & chimeric IAVs using viral genome sequence alone. This platform could be useful for generating vaccine seed strains or to study anti-viral immunity.

synthetic biology↗